Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.58 |
| ▸ | CYP2A6 | P11509 | 5/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 7/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.47 |
| ▸ | HPGD | P15428 | 4/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.47 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | DRD1 | P21728 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
| ▸ | HTR2B | P41595 | 1/20 | 0.47 |
| ▸ | CCR2 | P41597 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | CHAT | P28329 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL49212 | 0.87 | ALDH1A1 (0.58) | ALDH1A1CYP2A6CYP1A2HSD17B10HPGD | |
| SCHEMBL5143493 | 0.82 | ALDH1A1 (0.46) | ALDH1A1CYP2A6CYP1A2HSD17B10HPGD | |
| SCHEMBL702526 | 0.82 | TSHR (0.53) | ALDH1A1CYP2A6CYP1A2HPGDCYP3A4 | |
| SCHEMBL6541655 | 0.77 | HPRT1 (0.61) | ALDH1A1CYP2A6CYP1A2HSD17B10HPGD | |
| SCHEMBL5145155 | 0.76 | RAB9A (0.51) | ALDH1A1CYP2A6CYP1A2HSD17B10HPGD | |
| SCHEMBL2254008 | 0.75 | SIGMAR1 (0.49) | ALDH1A1CYP2A6CYP1A2HSD17B10HPGD | |
| SCHEMBL29903166 | 0.74 | CYP2A6 (1.00) | ALDH1A1CYP2A6CYP1A2HSD17B10HPGD | |
| SCHEMBL10684163 | 0.74 | CYP2A6 (1.00) | ALDH1A1CYP2A6CYP1A2HSD17B10HPGD | |
| SCHEMBL7517852 | 0.74 | CYP2A6 (1.00) | ALDH1A1CYP2A6CYP1A2HSD17B10HPGD | |
| SCHEMBL3075 | 0.74 | CYP2A6 (1.00) | ALDH1A1CYP2A6CYP1A2HSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080207864-A1 | Organosilanes, Process For Production of the Same, and Use Thereof | SHARP KABUSHIKI KAISHA (JP) | 2008-08-28 | — | — | US | disclosed |
| US-7232617-B2 | Electroluminescent devices | CITYU RESEARCH LIMITED (CN) | 2007-06-19 | — | — | US | disclosed |
| US-6833202-B2 | Luminescent layer uses as salicylaldiminato Schiff bases or their metal complexes based on diaminomaleonitrile and salicylaldehyde derivatives as red-emitting materials; color chromaticity | CITY UNIVERSITY OF HONG KONG (CN) | 2004-12-21 | — | — | US | disclosed |
| US-20040180234-A1 | Electroluminescent devices | HONG KONG, CITY UNIVERSITY OF (CN) | 2004-09-16 | — | — | US | disclosed |
| US-20040151943-A1 | Electroluminescent devices | INTELLECTUAL VENTURES II LLC | 2004-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040180234-A1 | Electroluminescent devices | SLC25A13, AOC1, DDT | ALDH1A1 37/4885CYP2A6 3397/4885CYP1A2 2986/4885 |
| US-20040151943-A1 | Electroluminescent devices | SLCO2B1, SLCO2A1, HAX1 | ALDH1A1 560/4885CYP2A6 1895/4885CYP1A2 1073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.